Nasus Pharma (NSRX) Profit Margin
Nasus Pharma (NSRX) profit margin history. The current Nasus Pharma (NSRX) profit margin is -0.47%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Annual Profit Margin change of Nasus Pharma (NSRX)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -0.47% | N/A |
Comparison Nasus Pharma (NSRX) profit margin with competitors
Nasus Pharma (NSRX) profit margin is -0.47%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | -10669.16% |
| LLY | Lilly(Eli) & Company | 37.36% | -7973.65% |
| GILD | Gilead Sciences Inc | 29.04% | -6220.20% |
| NVS | Novartis AG | 23.34% | -5018.92% |
| BMY | Bristol-Myers Squibb Company | 23.30% | -5010.49% |
| GSK | GSK Plc | 22.77% | -4898.80% |
| JNJ | Johnson & Johnson | 21.76% | -4685.94% |
| AMGN | AMGEN Inc | 21.11% | -4548.95% |
| AZN | Astrazeneca plc | 20.15% | -4346.63% |
| PFE | Pfizer Inc | 18.59% | -4017.86% |
| SNY | Sanofi | 14.35% | -3124.27% |
| BIIB | Biogen Inc | 12.89% | -2816.58% |
| OGN | Organon & Company | 10.00% | -2207.51% |
| ABBV | Abbvie Inc | 4.63% | -1075.78% |
| GRFS | Grifols SA | 4.29% | -1004.12% |